Our news

  • Cochrane Drugs and Alcohol specialises in reviews that assess, among other things, ways to reduce hazardous or harmful drinking of alcohol. One of these reviews looks at the evidence on practitioner-delivered brief interventions and we asked one of the authors, Fiona Beyer from Newcastle University in the UK to tell us about the findings from the...
    July 10 2018
  • Findings indicate talking therapy may be beneficial but more higher-quality research evidence is needed, particularly for children and adolescents.Adults and children and adolescents living in humanitarian contexts (such as in the aftermath of a crisis triggered by natural hazards) in low- and middle-income countries (LMICs) are exposed to...
    July 9 2018
  • Karen Morley blogs about her experience of seeking help for her Obsessive-Compulsive Disorder (OCD) and how finding and using Cochrane evidence was a turning point. This blog post was originally published on Evidently Cochrane.Without knowing what it was, I had experienced episodes of Obsessive-Compulsive Disorder (OCD) since I was an adolescent,...
    July 4 2018
  • Coping with the increasing number of people with dementia is likely to be one of the major challenges for health systems globally in coming years and decades. There are several Cochrane Reviews of ways to treat or alleviate this condition and an updated review in March 2018 looks at the evidence for reminiscence therapy. We asked lead author, Bob...
    June 4 2018
  • Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the most frequently used medication to treat it. Several studies have investigated the benefits of methylphenidate, showing possible favourable effects on ADHD symptoms, but the true magnitude of the effect...
    May 10 2018
  • We are delighted to announce the appointment of Rebecca Syed as the new Deputy Coordinating Editor of Cochrane SchizophreniaSince graduating in medicine from Balliol College, Oxford University, Rebecca has become a board-certified psychiatrist in both the UK and Australia. She has lived and worked in clinical and research capacities in...
    May 10 2018
  • This Review from Cochrane Epilepsy found six clinical trials that included in analysis 1759 people with focal epilepsy. These trials were all randomised controlled trials (clinical studies where people were randomly put into one of two or more treatment groups) that compared the antiepileptic drug rufinamide (at doses between 200 mg per day and...
    April 30 2018
  • The Cochrane Developmental, Psychosocial and Learning Problems Group covers a wide range of topics relevant to the mental health of both adults and children in the more than 140 Cochrane Reviews it has produced to date. In March 2018, it added to these with a new review of cognitive-behavioural interventions for attention deficit hyperactivity...
    April 10 2018
  • A Cochrane Review published in October 2014 by Cochrane Epilepsy highlights current evidence about the intelligence of children born to women taking antiepileptic medication. One medication, valproate, is of particular concern as it is associated with a drop in IQ sufficient to impact on educational and employment opportunities. There was no...
    March 28 2018
  • World Alzheimer’s Day, September 21st of each year, is a day on which organizations around the world concentrate their efforts on raising awareness about Alzheimer’s and dementia. Alzheimer’s disease is the most common form of dementia, a group of disorders that impairs mental functioning.  Each year for World Alzheimer's Day, Cochrane...
    March 21 2018

Pages

Subscribe to Our news